Status:

COMPLETED

The Benefit of Hemodialysis Plus Hemoperfusion on Mortality

Lead Sponsor:

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborating Sponsors:

Shanghai Zhongshan Hospital

RenJi Hospital

Conditions:

End-stage Renal Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This multi-center, open-label, randomized controlled trial aims to investigate the efficacy of hemoperfusion (HP) combined with hemodialysis (HD) by evaluating all-cause mortality and cardiovascular m...

Detailed Description

In this HD/HPvsHD trial, we plan to enroll 1364 maintenance hemodialysis patients. Eleven medical centers in Shanghai Metropolitan area have explicitly expressed interest to participate. Participants ...

Eligibility Criteria

Inclusion

  • Patients must meet all of the following criteria are eligible:
  • Age ≥ 18 years old
  • Regular blood purification treatment at least 3 months before enrolled in this study
  • 3\) Standard Kt/V ≥ 1.2
  • Subjects with one of more of the following conditions will be excluded:
  • White blood cell count \< 4×10\^9/L and / or platelet count \< 100×10\^9/L
  • Cerebral hemorrhage in the past 12 weeks
  • MACEs in the past 8 weeks
  • Severe heart failure (New York Heart Association \[NYHA\] class IV)
  • Active gastrointestinal bleeding, or coagulation dysfunction
  • Malignant tumor
  • Active infection
  • Pregnancy or lactation 9) Mental disabilities

Exclusion

    Key Trial Info

    Start Date :

    December 1 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2021

    Estimated Enrollment :

    1362 Patients enrolled

    Trial Details

    Trial ID

    NCT03227770

    Start Date

    December 1 2017

    End Date

    December 31 2021

    Last Update

    August 29 2022

    Active Locations (11)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (11 locations)

    1

    Changhai Hospital

    Shanghai, Shanghai Municipality, China, 200000

    2

    Longhua Hospital Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China, 200000

    3

    RenJi Hospital

    Shanghai, Shanghai Municipality, China, 200000

    4

    Ruijin Hospital

    Shanghai, Shanghai Municipality, China, 200000

    The Benefit of Hemodialysis Plus Hemoperfusion on Mortality | DecenTrialz